NCT02647320 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin Status COMPLETED Phase PHASE2
NCT02647307 Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b Status COMPLETED Phase PHASE1
NCT02633800 Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN ) Status TERMINATED Phase PHASE2
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02586233 Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke Status COMPLETED Phase PHASE1/PHASE2
NCT02584647 PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02569528 ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1 Status COMPLETED Phase N/A
NCT02567461 Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel Status COMPLETED Phase PHASE4
NCT02565823 The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue Status COMPLETED Phase NA
NCT02564900 Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT02560688 Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02533960 Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime Status COMPLETED Phase N/A
NCT02530918 Study of DS-7080a for the Treatment of Macular Degeneration Status COMPLETED Phase PHASE1
NCT02514304 Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding Status COMPLETED Phase N/A
NCT02496884 Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease Status COMPLETED Phase PHASE3
NCT02478177 Addressing Real-world Anticoagulant Management Issues in Stroke Status COMPLETED Phase N/A
NCT02473627 A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS Status COMPLETED Phase PHASE1
NCT02452424 A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02448901 Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography Status UNKNOWN Phase N/A